ArticlePloS one2014

Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.

Lei Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.